Daniel Polyak

Daniel Polyak, PhD, is a Senior Scientist at Merck, specializing in synthetic chemistry and drug development. With 1.5 years of experience in the pharmaceutical industry, Daniel has contributed to preclinical and clinical-stage programs in neuroscience and oncology, focusing on small molecule drug discovery and chemical process optimization. Previously, Daniel worked as a Principal Scientist I at Parexel, developing chemical processes for antibody-drug conjugates, and has held various roles at Alkermes and Brandeis University, where they supported both teaching and research in organic chemistry. Daniel earned a PhD in Organic Chemistry from Brandeis University and a BA in Chemistry from Rutgers University.